About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Updates in HR-MDS and AML
Updates in HR-MDS and AML
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
T
SOHO 2021: Novel Strategies to Treat Elderly With AML
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Tapan Kadia
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Tapan Kadia
124 views
September 30, 2021
0 Comments
Login to view comments.
Click here to Login
Updates in HR-MDS and AML
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: A Primer on the Biology of MDS
Feat.
S. Colla
09:36
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on the Role of Oral HMAs in MDS
Feat.
G. Garcia-Manero
15:41
3rd Annual Hematologic Malignancies Symposium
IDH Inhibitors in MDS: Frequency & Prognosis, Mutations, Therapy…
Feat.
A. Wei
09:10
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Novel Strategies to Treat Elderly With AML
Feat.
T. Kadia
06:04
ASH 2021 Conference Coverage on VuMedi
ASH 2021 Clinical and Pathological Characteristics of Hypocellular M…
Feat.
K. Kim
11:04
ASH 2021 Conference Coverage on VuMedi
ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with …
Feat.
J. Bewersdorf
04:45
ASH 2021 Conference Coverage on VuMedi
ASH 2021 on LR-MDS: Factors Predicting Progression to HR-MDS and AML…
Feat.
A. Jain
14:11
MDS Foundation
MDS Foundation ASH 2021 Review: When and How Genetic Predisposition …
Feat.
L. Malcovati
23:13
MDS Foundation
MDS Foundation ASH 2021 Review: Towards a Genetically Inspired Class…
Feat.
E. Bernard
36:53
University of Colorado Division of Hematology
UC Denver ASH Review: Updates on MDS & AML
Feat.
C. McMahon
19:55
MDS Foundation
Inflammatory Signaling in the Pathogenesis of MDS
Feat.
D. Sallman
25:29
MDS Foundation
Bone Marrow Niche Contributions to MDS Pathogenesis
Feat.
H. Medyouf
18:14
Yale Cancer Center
ASH 2021 Highlights for AML
Feat.
R. Shallis
21:44
MDS Foundation
MDS Foundation ASH 2021 Review: Can Transplantation Improve Survival…
Feat.
G. Mufti
23:56
MDS Foundation
Role of Innate Immune Signaling in MDS
Feat.
D. Starczynowski